GU

GUProstate cancerWND GU

Episode 22: PSMA-based radioligand therapy: a new treatment modality for patients with metastatic castration-resistant prostate cancer

1 July 2024

In this new episode of ‘What’s New Doc’ in Prostate cancer, Prof Bertrand...

GUProstate cancerWND GU

Episode 21: Neoadjuvant degarelix with or without apalutamide prior to surgery for high-risk prostate cancer: results of the phase II ARNEO trial

24 June 2024

In this new episode of ‘What’s New Doc’ in Prostate cancer, Prof Bertrand...

GUProstate cancerWND GU

Episode 20: Dose-escalated radiotherapy with or without short-term ADT for patients with intermediate-risk prostate cancer

17 June 2024

In this new episode of ‘What’s New Doc’ in Prostate cancer, Prof Bertrand...

GUProstate cancerWND GU

Episode 19: Relugolix as hormone therapy for men with advanced prostate cancer: results from the HERO trial

10 June 2024

In this new episode of ‘What’s New Doc’ in Prostate cancer, Prof Bertrand...

GUProstate cancerWND GU

Episode 18: PSA-based screening for prostate cancer: 21-year follow-up of the Rotterdam section of the ERSPC study

3 June 2024

In this new episode of ‘What’s New Doc’ in Prostate cancer, Prof Bertrand...

GUProstate cancerWND GU

Episode 17: Prostate irradiation for men with newly-diagnosed, metastatic castration-sensitive prostate cancer: new insights from PEACE-1

27 May 2024

In this new episode of ‘What’s New Doc’ in Prostate cancer, Prof Bertrand...

GUProstate cancerWND GU

Episode 16: Active surveillance solidified as standard of care for patients with low-risk, localized prostate cancer: 15-year update from ProtecT

20 May 2024

In this new episode of WND Prostate cancer, Prof Bertrand Tombal from the...

GUProstate cancerWND GU

Episode 15: Adding stereotactic radiotherapy to abiraterone acetate significantly delays disease progression in oligometastatic CRPC patients: the ARTO trial

13 May 2024

In this new episode of ‘What’s New Doc’ in Prostate cancer, Prof Bertrand...

GUProstate cancerWND GU

Episode 14: Improved clinical outcomes with the combination of olaparib and abiraterone-acetate in the 1st line treatment of metastatic CRPC

6 May 2024

In this new episode of WND Prostate cancer, Prof Bertrand Tombal from the...

GUProstate cancerWND GU

Episode 13: Enzalutamide for biochemically recurrent prostate cancer: reflections on the EMBARK trial

29 April 2024

In this first episode of WND Prostate cancer, Prof Bertrand Tombal from the...